Nasdaq
GRCE
Grace Therapeutics, Inc.
- Health Care
- Canada
- 1 day
- −0.9%
- 1 month
- −15.5%
- 1 year
- −28.6%
$2.12 · Mkt cap $28.4M
At the 6 Aug 2026 close
Nasdaq
Grace Therapeutics, Inc.
$2.12 · Mkt cap $28.4M
At the 6 Aug 2026 close
Grace Therapeutics, Inc. trades under the ticker GRCE on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $28.4M. The last closing price was $2.12, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −28.6%, and −15.5% over the past month. Returns are price returns and exclude dividends.
This page exists because GRCE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.